Intrinsic value of PetIQ Cl A - PETQ

Previous Close

$28.69

  Intrinsic Value

$631.73

stock screener

  Rating & Target

str. buy

+999%

Previous close

$28.69

 
Intrinsic value

$631.73

 
Up/down potential

+999%

 
Rating

str. buy

We calculate the intrinsic value of PETQ stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 0.5

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  60.00
  54.50
  49.55
  45.10
  41.09
  37.48
  34.23
  31.31
  28.68
  26.31
  24.18
  22.26
  20.53
  18.98
  17.58
  16.32
  15.19
  14.17
  13.26
  12.43
  11.69
  11.02
  10.42
  9.87
  9.39
  8.95
  8.55
  8.20
  7.88
  7.59
Revenue, $m
  427
  659
  986
  1,431
  2,018
  2,775
  3,724
  4,890
  6,293
  7,948
  9,870
  12,067
  14,544
  17,305
  20,348
  23,669
  27,265
  31,129
  35,255
  39,637
  44,269
  49,147
  54,266
  59,625
  65,222
  71,058
  77,136
  83,460
  90,036
  96,870
Variable operating expenses, $m
  346
  535
  799
  1,159
  1,635
  2,248
  3,017
  3,961
  5,097
  6,438
  7,993
  9,773
  11,779
  14,015
  16,479
  19,169
  22,081
  25,211
  28,552
  32,101
  35,853
  39,803
  43,949
  48,289
  52,822
  57,549
  62,471
  67,593
  72,918
  78,453
Fixed operating expenses, $m
  38
  39
  39
  40
  41
  42
  43
  44
  45
  46
  47
  48
  49
  50
  51
  52
  54
  55
  56
  57
  58
  60
  61
  62
  64
  65
  67
  68
  70
  71
Total operating expenses, $m
  384
  574
  838
  1,199
  1,676
  2,290
  3,060
  4,005
  5,142
  6,484
  8,040
  9,821
  11,828
  14,065
  16,530
  19,221
  22,135
  25,266
  28,608
  32,158
  35,911
  39,863
  44,010
  48,351
  52,886
  57,614
  62,538
  67,661
  72,988
  78,524
Operating income, $m
  42
  86
  147
  231
  342
  485
  664
  885
  1,151
  1,464
  1,829
  2,246
  2,716
  3,240
  3,817
  4,448
  5,130
  5,864
  6,647
  7,479
  8,358
  9,284
  10,256
  11,274
  12,337
  13,445
  14,599
  15,800
  17,048
  18,346
EBITDA, $m
  48
  94
  159
  247
  365
  516
  706
  939
  1,220
  1,552
  1,938
  2,378
  2,876
  3,430
  4,040
  4,707
  5,429
  6,205
  7,034
  7,914
  8,844
  9,823
  10,851
  11,928
  13,052
  14,224
  15,445
  16,715
  18,036
  19,409
Interest expense (income), $m
  3
  1
  4
  9
  15
  23
  34
  48
  66
  88
  115
  146
  182
  223
  270
  322
  379
  442
  509
  582
  660
  742
  830
  921
  1,018
  1,119
  1,224
  1,334
  1,448
  1,567
  1,691
Earnings before tax, $m
  41
  82
  139
  216
  319
  450
  616
  819
  1,062
  1,350
  1,684
  2,064
  2,493
  2,970
  3,495
  4,068
  4,688
  5,354
  6,065
  6,819
  7,616
  8,455
  9,335
  10,256
  11,218
  12,221
  13,265
  14,351
  15,481
  16,655
Tax expense, $m
  11
  22
  37
  58
  86
  122
  166
  221
  287
  364
  455
  557
  673
  802
  944
  1,098
  1,266
  1,446
  1,637
  1,841
  2,056
  2,283
  2,520
  2,769
  3,029
  3,300
  3,582
  3,875
  4,180
  4,497
Net income, $m
  30
  60
  101
  158
  233
  329
  450
  598
  775
  985
  1,229
  1,507
  1,820
  2,168
  2,552
  2,970
  3,423
  3,909
  4,427
  4,978
  5,560
  6,172
  6,814
  7,487
  8,189
  8,921
  9,683
  10,477
  11,301
  12,158

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  193
  299
  447
  648
  914
  1,257
  1,688
  2,216
  2,851
  3,601
  4,472
  5,467
  6,590
  7,841
  9,220
  10,725
  12,354
  14,105
  15,974
  17,960
  20,059
  22,269
  24,588
  27,016
  29,552
  32,197
  34,951
  37,816
  40,795
  43,892
Adjusted assets (=assets-cash), $m
  193
  299
  447
  648
  914
  1,257
  1,688
  2,216
  2,851
  3,601
  4,472
  5,467
  6,590
  7,841
  9,220
  10,725
  12,354
  14,105
  15,974
  17,960
  20,059
  22,269
  24,588
  27,016
  29,552
  32,197
  34,951
  37,816
  40,795
  43,892
Revenue / Adjusted assets
  2.212
  2.204
  2.206
  2.208
  2.208
  2.208
  2.206
  2.207
  2.207
  2.207
  2.207
  2.207
  2.207
  2.207
  2.207
  2.207
  2.207
  2.207
  2.207
  2.207
  2.207
  2.207
  2.207
  2.207
  2.207
  2.207
  2.207
  2.207
  2.207
  2.207
Average production assets, $m
  29
  45
  67
  97
  137
  189
  253
  333
  428
  540
  671
  821
  989
  1,177
  1,384
  1,609
  1,854
  2,117
  2,397
  2,695
  3,010
  3,342
  3,690
  4,054
  4,435
  4,832
  5,245
  5,675
  6,122
  6,587
Working capital, $m
  84
  131
  195
  283
  400
  549
  737
  968
  1,246
  1,574
  1,954
  2,389
  2,880
  3,426
  4,029
  4,686
  5,398
  6,164
  6,981
  7,848
  8,765
  9,731
  10,745
  11,806
  12,914
  14,070
  15,273
  16,525
  17,827
  19,180
Total debt, $m
  62
  126
  217
  340
  502
  712
  975
  1,298
  1,686
  2,144
  2,676
  3,284
  3,970
  4,735
  5,577
  6,496
  7,492
  8,562
  9,704
  10,917
  12,200
  13,550
  14,967
  16,451
  18,000
  19,616
  21,299
  23,049
  24,870
  26,762
Total liabilities, $m
  118
  183
  273
  396
  559
  768
  1,031
  1,354
  1,742
  2,200
  2,732
  3,341
  4,027
  4,791
  5,633
  6,553
  7,548
  8,618
  9,760
  10,973
  12,256
  13,606
  15,023
  16,507
  18,056
  19,672
  21,355
  23,106
  24,926
  26,818
Total equity, $m
  75
  116
  174
  252
  356
  489
  656
  862
  1,109
  1,401
  1,740
  2,127
  2,564
  3,050
  3,586
  4,172
  4,806
  5,487
  6,214
  6,986
  7,803
  8,663
  9,565
  10,509
  11,496
  12,525
  13,596
  14,710
  15,869
  17,074
Total liabilities and equity, $m
  193
  299
  447
  648
  915
  1,257
  1,687
  2,216
  2,851
  3,601
  4,472
  5,468
  6,591
  7,841
  9,219
  10,725
  12,354
  14,105
  15,974
  17,959
  20,059
  22,269
  24,588
  27,016
  29,552
  32,197
  34,951
  37,816
  40,795
  43,892
Debt-to-equity ratio
  0.820
  1.090
  1.250
  1.350
  1.410
  1.460
  1.480
  1.510
  1.520
  1.530
  1.540
  1.540
  1.550
  1.550
  1.560
  1.560
  1.560
  1.560
  1.560
  1.560
  1.560
  1.560
  1.560
  1.570
  1.570
  1.570
  1.570
  1.570
  1.570
  1.570
Adjusted equity ratio
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389
  0.389

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  30
  60
  101
  158
  233
  329
  450
  598
  775
  985
  1,229
  1,507
  1,820
  2,168
  2,552
  2,970
  3,423
  3,909
  4,427
  4,978
  5,560
  6,172
  6,814
  7,487
  8,189
  8,921
  9,683
  10,477
  11,301
  12,158
Depreciation, amort., depletion, $m
  6
  8
  12
  17
  23
  31
  42
  54
  70
  88
  108
  132
  160
  190
  223
  260
  299
  341
  387
  435
  486
  539
  595
  654
  715
  779
  846
  915
  987
  1,062
Funds from operations, $m
  36
  68
  113
  174
  255
  360
  491
  652
  845
  1,073
  1,337
  1,639
  1,979
  2,358
  2,775
  3,230
  3,722
  4,250
  4,814
  5,413
  6,045
  6,711
  7,410
  8,141
  8,904
  9,700
  10,529
  11,392
  12,289
  13,221
Change in working capital, $m
  32
  46
  65
  88
  116
  150
  188
  231
  278
  328
  380
  435
  491
  547
  602
  658
  712
  765
  817
  868
  917
  966
  1,014
  1,061
  1,108
  1,156
  1,203
  1,252
  1,302
  1,353
Cash from operations, $m
  4
  22
  48
  86
  139
  210
  303
  421
  568
  745
  957
  1,204
  1,489
  1,811
  2,172
  2,572
  3,010
  3,485
  3,997
  4,545
  5,128
  5,745
  6,396
  7,080
  7,796
  8,545
  9,326
  10,140
  10,987
  11,867
Maintenance CAPEX, $m
  -3
  -5
  -7
  -11
  -16
  -22
  -30
  -41
  -54
  -69
  -87
  -108
  -132
  -160
  -190
  -223
  -260
  -299
  -341
  -387
  -435
  -486
  -539
  -595
  -654
  -715
  -779
  -846
  -915
  -987
New CAPEX, $m
  -11
  -16
  -22
  -30
  -40
  -51
  -65
  -79
  -95
  -113
  -131
  -149
  -168
  -188
  -207
  -226
  -245
  -263
  -281
  -298
  -315
  -332
  -348
  -364
  -381
  -397
  -413
  -430
  -447
  -465
Cash from investing activities, $m
  -14
  -21
  -29
  -41
  -56
  -73
  -95
  -120
  -149
  -182
  -218
  -257
  -300
  -348
  -397
  -449
  -505
  -562
  -622
  -685
  -750
  -818
  -887
  -959
  -1,035
  -1,112
  -1,192
  -1,276
  -1,362
  -1,452
Free cash flow, $m
  -10
  1
  19
  45
  83
  137
  208
  301
  419
  564
  739
  947
  1,188
  1,464
  1,776
  2,123
  2,505
  2,923
  3,375
  3,860
  4,378
  4,928
  5,509
  6,120
  6,762
  7,433
  8,133
  8,864
  9,624
  10,415
Issuance/(repayment) of debt, $m
  44
  64
  90
  123
  163
  209
  263
  323
  388
  458
  532
  608
  686
  764
  842
  920
  995
  1,070
  1,142
  1,213
  1,282
  1,350
  1,417
  1,484
  1,550
  1,616
  1,683
  1,751
  1,820
  1,892
Issuance/(repurchase) of shares, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  44
  64
  90
  123
  163
  209
  263
  323
  388
  458
  532
  608
  686
  764
  842
  920
  995
  1,070
  1,142
  1,213
  1,282
  1,350
  1,417
  1,484
  1,550
  1,616
  1,683
  1,751
  1,820
  1,892
Total cash flow (excl. dividends), $m
  34
  66
  109
  168
  246
  346
  471
  624
  807
  1,022
  1,271
  1,555
  1,874
  2,228
  2,618
  3,042
  3,501
  3,993
  4,517
  5,073
  5,661
  6,278
  6,926
  7,604
  8,311
  9,048
  9,816
  10,614
  11,445
  12,307
Retained Cash Flow (-), $m
  -28
  -41
  -58
  -78
  -104
  -133
  -167
  -206
  -247
  -292
  -339
  -387
  -437
  -487
  -536
  -585
  -634
  -681
  -727
  -772
  -816
  -860
  -902
  -944
  -987
  -1,029
  -1,071
  -1,115
  -1,159
  -1,205
Prev. year cash balance distribution, $m
  20
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  26
  25
  52
  90
  143
  213
  304
  418
  560
  730
  932
  1,168
  1,437
  1,742
  2,082
  2,457
  2,867
  3,312
  3,790
  4,301
  4,844
  5,419
  6,024
  6,659
  7,325
  8,020
  8,745
  9,500
  10,286
  11,103
Discount rate, %
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
  25
  22
  45
  74
  111
  154
  205
  261
  322
  383
  443
  498
  546
  585
  611
  624
  624
  610
  584
  547
  501
  450
  395
  339
  285
  234
  188
  147
  112
  84
Current shareholders' claim on cash, %
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

PetIQ, Inc. is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. It distributes the products through veterinarian, retail and e-commerce channels. The Company offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The Company manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The Company also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products.

FINANCIAL RATIOS  of  PetIQ Cl A (PETQ)

Valuation Ratios
P/E Ratio -197.9
Price to Sales 3
Price to Book 14.5
Price to Tangible Book
Price to Cash Flow -593.6
Price to Free Cash Flow -197.9
Growth Rates
Sales Growth Rate -2.9%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 0%
Cap. Spend. - 3 Yr. Gr. Rate NaN%
Financial Strength
Quick Ratio 1
Current Ratio 0.1
LT Debt to Equity 63.4%
Total Debt to Equity 68.3%
Interest Coverage 0
Management Effectiveness
Return On Assets 0%
Ret/ On Assets - 3 Yr. Avg. -8.6%
Return On Total Capital -4.1%
Ret/ On T. Cap. - 3 Yr. Avg. -13.5%
Return On Equity -6.9%
Return On Equity - 3 Yr. Avg. -18.3%
Asset Turnover 2.3
Profitability Ratios
Gross Margin 16.5%
Gross Margin - 3 Yr. Avg. 16.6%
EBITDA Margin 2%
EBITDA Margin - 3 Yr. Avg. -0.2%
Operating Margin -0.5%
Oper. Margin - 3 Yr. Avg. -2.1%
Pre-Tax Margin -1.5%
Pre-Tax Margin - 3 Yr. Avg. -2.9%
Net Profit Margin -1.5%
Net Profit Margin - 3 Yr. Avg. -2.9%
Effective Tax Rate 0%
Eff/ Tax Rate - 3 Yr. Avg. 0%
Payout Ratio 0%

PETQ stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the PETQ stock intrinsic value calculation we used $266.687 million for the last fiscal year's total revenue generated by PetIQ Cl A. The default revenue input number comes from 0001 income statement of PetIQ Cl A. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our PETQ stock valuation model: a) initial revenue growth rate of 60% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for PETQ is calculated based on our internal credit rating of PetIQ Cl A, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of PetIQ Cl A.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of PETQ stock the variable cost ratio is equal to 81.3%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $37 million in the base year in the intrinsic value calculation for PETQ stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 6.8% for PetIQ Cl A.

Corporate tax rate of 27% is the nominal tax rate for PetIQ Cl A. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the PETQ stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for PETQ are equal to 6.8%.

Life of production assets of 6.2 years is the average useful life of capital assets used in PetIQ Cl A operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for PETQ is equal to 19.8%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $66.714 million for PetIQ Cl A - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 16.132 million for PetIQ Cl A is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of PetIQ Cl A at the current share price and the inputted number of shares is $0.5 billion.

COMPANY NEWS

▶ PetIQ: 3Q Earnings Snapshot   [04:57PM  Associated Press]
▶ Who Joins Square On This List Of Today's Fastest-Growing Companies?   [Nov-09-18 04:05PM  Investor's Business Daily]
▶ PetIQ, Inc. Announces Public Offering of Common Stock   [Sep-24-18 04:01PM  GlobeNewswire]
▶ PetIQ Has Broken Out on the Upside - Time to Go Long   [Aug-22-18 09:01AM  TheStreet.com]
▶ PetIQ (PETQ) Catches Eye: Stock Jumps 9.1%   [Aug-21-18 08:33AM  Zacks]
▶ These 3 Stocks Crushed It This Week: Are They Buys Now?   [Aug-18-18 08:32AM  Motley Fool]
▶ Why PetIQ, Inc. Is Soaring Today   [10:57AM  Motley Fool]
▶ PetIQ: 2Q Earnings Snapshot   [Aug-14-18 04:28PM  Associated Press]
▶ PetIQ: 1Q Earnings Snapshot   [May-15-18 04:51PM  Associated Press]
▶ PetIQ, Inc. Expands Its Board of Directors   [Mar-19-18 04:05PM  GlobeNewswire]
▶ Benzinga Pro's 5 Stocks To Watch Today   [Mar-14-18 08:53AM  Benzinga]
▶ 8 Stocks Moving In Tuesday's After-Hours Session   [Mar-13-18 06:26PM  Benzinga]
▶ PetIQ reports 4Q loss   [04:55PM  Associated Press]
▶ PetIQ, Inc. Completes Strategic Acquisition of VIP Petcare   [Jan-17-18 05:06PM  GlobeNewswire]
▶ IBD Rating Upgrades: Michaels Flashes Improved Price Strength   [Sep-07-17 03:00AM  Investor's Business Daily]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.